A wiki provides one of the most effective solutions for building organizational knowledge bases, community information ...
Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
Web developers are moving away from the library wars and into a world of architectural choice. It’s about where you want the ...
Recently observed Trigona ransomware attacks are using a custom, command-line tool to steal data from compromised ...
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
The collection — the largest of its kind — contains more than 18,700 adverts that were posted between March 2020 and early ...
As we mark the first year of building Edits, we're sharing a look back and a preview of what we’re excited to build next.
Apr. 7, 2026 A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results